64 related articles for article (PubMed ID: 2027244)
1. [Plasma concentrations of plasminogen activator inhibitor 2 in patients with hematological malignancies and their clinical significance].
Shimmyozu K; Machigashira N; Itoyama T; Tara M; Maruyama I; Osame M
Rinsho Ketsueki; 1991 Feb; 32(2):173-5. PubMed ID: 2027244
[TBL] [Abstract][Full Text] [Related]
2. [Peculiar increase of plasma plasminogen activator inhibitor 1 levels in patients with hemophagocytic histiocytosis].
Shimmyozu K; Kadokura N; Itoyama T; Tara M; Maruyama I; Osame M
Rinsho Ketsueki; 1990 Jan; 31(1):127-8. PubMed ID: 2313902
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-2 in patients with monocytic leukemia.
Scherrer A; Kruithof EK; Grob JP
Leukemia; 1991 Jun; 5(6):479-86. PubMed ID: 2056772
[TBL] [Abstract][Full Text] [Related]
4. [Increase of serum acidic isoferritins in patients with hemophagocytic histiocytosis].
Shimmyozu K; Kadokura N; Itoyama T; Tara M; Maruyama I; Osame M
Rinsho Ketsueki; 1990 Jul; 31(7):1036-7. PubMed ID: 2214186
[TBL] [Abstract][Full Text] [Related]
5. [The significance of plasminogen activator inhibitor 2 in patients with hematologic malignancies].
Cetkovský P; Koza V; Cepelák V; Vít L
Vnitr Lek; 1993 Sep; 39(9):871-5. PubMed ID: 8212641
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
7. Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis.
Páramo JA; Pérez JL; Serrano M; Rocha E
Thromb Haemost; 1990 Aug; 64(1):3-6. PubMed ID: 2274926
[TBL] [Abstract][Full Text] [Related]
8. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
9. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
13. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.
Juhan-Vague I; Roul C; Alessi MC; Ardissone JP; Heim M; Vague P
Thromb Haemost; 1989 Jun; 61(3):370-3. PubMed ID: 2678583
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.
Pralong G; Calandra T; Glauser MP; Schellekens J; Verhoef J; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Jun; 61(3):459-62. PubMed ID: 2678584
[TBL] [Abstract][Full Text] [Related]
15. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
Lai HS; Chen Y; Chang KJ; Chen WJ
J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
[TBL] [Abstract][Full Text] [Related]
16. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
17. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
Booth NA; Reith A; Bennett B
Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
[TBL] [Abstract][Full Text] [Related]
18. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
19. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
Chen HZ; Jia HY; Song HY; Wang JY
Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
